Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: IMPROVE-VTE

Venous thromboembolism, defined as deep vein thrombosis or pulmonary embolism, is a major health concern in the United States, with more than 900,000 thrombotic events reported each year, resulting in at least 600,000 hospitalizations and approximately100,000 deaths.1-3 Total treatment costs during the initial year after an index venous thromboembolism have been estimated to surpass $20,000 per patient.4

About admin

Now Dr. Jack Straw is in charge of the website, and organizes it so that medical care is available to everyone. In addition, he is an active member of the medical community, regularly attending international conferences and sharing his experience and knowledge. Dr. Straw is not only a medical professional and website manager, but also a loving husband and father of his beautiful children.
View all posts by admin →

Leave a Reply

Your email address will not be published. Required fields are marked *